No article text was recorded for this version.
viral variant evolution
Version 1 of 195 papers116 conceptsfrozen 2026-10-04
Papers in this version
- Blog: The Protective Efficacy of a SARS-CoV-2 Vaccine Candidate B.1.351V against Several Variant Challenges in K18-hACE2 Mice
- Blog: Lineage Replacement and Genetic Changes of Four HR-HPV Types during the Period of Vaccine Coverage: A Six-Year Retrospective Study in Eastern China
- Blog: A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model
- Blog: The Spread of SARS-CoV-2 Variant Omicron with a Doubling Time of 2.0–3.3 Days Can Be Explained by Immune Evasion
- Blog: Development of a Dissemination Platform for Spatiotemporal and Phylogenetic Analysis of Avian Infectious Bronchitis Virus
- Blog: Tracking SARS-CoV-2 Spike Protein Mutations in the United States (January 2020—March 2021) Using a Statistical Learning Strategy
- Blog: Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
- Blog: Sieve analysis to understand how SARS-CoV-2 diversity can impact vaccine protection
- Blog: Excess burden of respiratory and abdominal conditions following COVID-19 infections during the ancestral and Delta variant periods in the United States: An EHR-based cohort study from the RECOVER program
- Blog: Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England
- Blog: Evolving SARS-CoV-2 Vaccines: From Current Solutions to Broad-Spectrum Protection
- Blog: Rapid and Visual Detection of SARS-CoV-2 RNA Based on Reverse Transcription-Recombinase Polymerase Amplification with Closed Vertical Flow Visualization Strip Assay
- Blog: A Novel COVID-19 Diagnostic System Using Biosensor Incorporated Artificial Intelligence Technique
- Blog: Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization
- Blog: Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants
- Blog: A quadri-fluorescence SARS-CoV-2 pseudovirus system for efficient antigenic characterization of multiple circulating variants
- Blog: Upsurge of Enterovirus D68 and Circulation of the New Subclade D3 and Subclade B3 in Beijing, China, 2016
- Blog: Projected resurgence of COVID-19 in the United States in July—December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccination
- Blog: Household transmission of SARS-CoV-2 during the Omicron wave in Shanghai, China:a case-ascertained study
- Blog: The possible impact of novel mutations in human papillomavirus 52 on the infection characteristics
- Blog: RV144 vaccine imprinting constrained HIV-1 evolution following breakthrough infection
- Blog: COVID-19 dynamics after a national immunization program in Israel
- Blog: Enhanced neutralization of SARS-CoV-2 XBB sub-lineages and BA.2.86 by a tetravalent COVID-19 vaccine booster
- Blog: International Importation Risk Estimation of SARS-CoV-2 Omicron Variant with Incomplete Mobility Data
- Blog: Nasal irrigation efficiently attenuates SARS-CoV-2 Omicron infection, transmission and lung injury in the Syrian hamster model
- Blog: International genomic definition of pneumococcal lineages, to contextualise disease, antibiotic resistance and vaccine impact
- Blog: A Bioinformatics Approach to Investigate Structural and Non-Structural Proteins in Human Coronaviruses
- Blog: <i>In silico</i> design of immunogenic antigen cocktail via affinity maturation-guided optimization
- Blog: 1218. Genotypic Investigation of a Rotavirus Cluster at a Pediatric Hospital in 2022
- Blog: Whole Genome Sequencing of Lumpy Skin Disease Virus from 2021–2023 in Eastern Eurasia Reveals No More Recombination Signals in the Circulating Pool of Strains
- Blog: Persistent Laplacian projected Omicron BA.4 and BA.5 to become new dominating variants
- Blog: Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 Transmission
- Blog: Multi-Stage Temporal Convolution Network for COVID-19 Variant Classification
- Blog: Emerging Hypervirulent Marek’s Disease Virus Variants Significantly Overcome Protection Conferred by Commercial Vaccines
- Blog: SARS‐CoV‐2 booster immunization: stimulating de novo B‐cell response and antibody generation
- Blog: Predicting high-fitness viral protein variants with Bayesian active learning and biophysics
- Blog: Robust humoral and cellular immune responses in long-term convalescent COVID-19 individuals following one-dose SARS-CoV-2 inactivated vaccination
- Blog: Impact of SARS-CoV-2 vaccination of children ages 5–11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021–March 2022: a multi-model study
- Blog: Emerging Dominant SARS-CoV-2 Variants
- Blog: Vaccine‐Associated Recombination and Virulence Heterogeneity of GI‐19 (QX Type) Infectious Bronchitis Virus in Eastern and Southern China, 2024−2025
- Blog: PRIEST: predicting viral mutations with immune escape capability of SARS-CoV-2 using temporal evolutionary information
- Blog: Resurgence of SARS-CoV-2 in India: Potential role of the B.1.617.2 (Delta) variant and delayed interventions
- Blog: Kinetics of severe acute respiratory syndrome coronavirus 2 infection antibody responses
- Blog: Forecasting emergence of COVID-19 variants of concern
- Blog: Effect of Omicron BA.1-based compared to prototype booster mRNA vaccination on incidence of COVID-19 in the COVAIL trial
- Blog: The minimal COVID-19 vaccination coverage and efficacy to compensate for a potential increase of transmission contacts, and increased transmission probability of the emerging strains
- Blog: Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination
- Blog: Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios — United States, April–September 2021
- Blog: Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody: mechanisms for the high infectivity, immune evasion and antibody drug discovery
- Blog: Functional antibody responses to SARS-CoV-2 variants before and after booster vaccination among adults in Ghana
- Blog: A Novel Targeted RIG-I Receptor 5′Triphosphate Double Strain RNA-Based Adjuvant Significantly Improves the Immunogenicity of the SARS-CoV-2 Delta-Omicron Chimeric RBD-Dimer Recombinant Protein Vaccine
- Blog: Will the next pandemic be caused by coronavirus again? An interview with George Fu Gao
- Blog: Global surveillance of emerging SARS-CoV-2 variants
- Blog: An Etiological Investigation of Domestic Cats with Conjunctivitis and Upper Respiratory Tract Disease in Japan.
- Blog: The Role of “Hierarchical and Classified Prevention and Control Measures (HCPC)” Strategy for SARS-CoV-2 Delta Variant in Guangzhou: A Modeling Study
- Blog: COVID-19 in early 2021: current status and looking forward
- Blog: Mathematical artificial intelligence design of mutation-proof COVID-19 monoclonal antibodies
- Blog: Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses
- Blog: Construction of pseudorabies virus variant attenuated vaccine: codon deoptimization of US3 and UL56 genes based on PRV gE/TK deletion strain
- Blog: Structural basis for receptor-binding domain mobility of the spike in SARS-CoV-2 BA.2.86 and JN.1
Showing 60 of 95 papers.
History & citation
Current · Permanent link
- This direction split from Predicting and Countering Viral Immune Escape (91% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_viral_variant_evolution_4ac612fd,
title = {viral variant evolution},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/viral-variant-evolution/rdr_4ac612fd2af643119d5336ad9b7ad652},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 1, frozen text):
@misc{lacuna_viral_variant_evolution_4ac612fd_v1,
title = {viral variant evolution},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/viral-variant-evolution/rdr_4ac612fd2af643119d5336ad9b7ad652/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}